The pharmaceutical industry’s patent defense system is a machine built on a single assumption: that the price of a drug […]

An investigative deep-dive for commercial leads, market access directors, and C-suite executives who negotiate with OptumRx, Express Scripts, and CVS

Every week, a medicinal chemistry team somewhere identifies a promising compound, runs it past the IP group, and asks a

Every procurement director who has watched a blockbuster drug lose market exclusivity knows the same thing in hindsight: the scramble

The 180-day generic drug exclusivity period is, by raw financial math, one of the most lucrative regulatory prizes in the

Mark Cuban launched Cost Plus Drugs in January 2022 with a simple premise: buy generic drugs at manufacturer cost, add

A billionaire’s drugstore startup exposed the $6 billion arbitrage game inside America’s pharmacy benefit system. Now the entire supply chain

Mark Cuban built his fortune by spotting inefficient markets and charging in with a simpler model. The Dallas Mavericks. HDNet.

In January 2022, Mark Cuban launched a pharmacy that listed drug prices on a public website. That alone was unusual.